Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry

Wealthfront Advisers LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Defense World ·  {{timeTz}}

Wealthfront Advisers LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 26.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,286 shares of the medical equipment provider's stock after selling 5,820 shares during the period. Wealthfront Advisers LLC's holdings in Intuitive Surgical were worth $3,269,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. IronBridge Private Wealth LLC increased its stake in shares of Intuitive Surgical by 200.0% during the 4th quarter. IronBridge Private Wealth LLC now owns 81 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 54 shares in the last quarter. Comprehensive Financial Consultants Institutional Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $30,000. JFS Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 145.2% during the 1st quarter. JFS Wealth Advisors LLC now owns 103 shares of the medical equipment provider's stock worth $31,000 after purchasing an additional 61 shares in the last quarter. Vectors Research Management LLC increased its stake in shares of Intuitive Surgical by 200.0% during the 4th quarter. Vectors Research Management LLC now owns 90 shares of the medical equipment provider's stock worth $32,000 after purchasing an additional 60 shares in the last quarter. Finally, MV Capital Management Inc. increased its stake in shares of Intuitive Surgical by 138.9% during the 2nd quarter. MV Capital Management Inc. now owns 172 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 100 shares in the last quarter. 82.44% of the stock is owned by hedge funds and other institutional investors.

Get Intuitive Surgical alerts:

Insider Activity

In other news, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $210.76, for a total value of $1,343,595.00. Following the transaction, the director now owns 11,224 shares of the company's stock, valued at approximately $2,365,570.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $210.76, for a total transaction of $1,343,595.00. Following the sale, the director now owns 11,224 shares of the company's stock, valued at approximately $2,365,570.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 9,000 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the sale, the executive vice president now directly owns 217 shares in the company, valued at approximately $48,825. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 101,162 shares of company stock valued at $22,062,916. Company insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on ISRG shares. Piper Sandler raised their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an "overweight" rating in a research report on Thursday, August 18th. Evercore ISI decreased their target price on shares of Intuitive Surgical from $210.00 to $175.00 in a research report on Friday, July 22nd. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $250.00 to $260.00 and gave the stock a "buy" rating in a research report on Friday, September 9th. The Goldman Sachs Group decreased their target price on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a research report on Friday, July 29th. Finally, Raymond James decreased their target price on shares of Intuitive Surgical from $294.00 to $255.00 in a research report on Friday, July 22nd. Six investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $268.00.

Intuitive Surgical Trading Down 0.9 %

Shares of ISRG stock opened at $187.44 on Friday. The company's fifty day simple moving average is $216.24 and its 200-day simple moving average is $229.94. Intuitive Surgical, Inc. has a 52 week low of $184.94 and a 52 week high of $369.69. The company has a market cap of $66.94 billion, a PE ratio of 47.69, a P/E/G ratio of 5.26 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. The business had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the business posted $1.42 EPS. Equities research analysts expect that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

Intuitive Surgical Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • Thor Industries Hammers Out A Bottom

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.